XPeng Inc. · XPEV · FY2025 Q3 · Calendar Q4 2025

XPeng pairs record growth with an ambitious AI and global expansion agenda

XPeng's latest call supports a constructive growth narrative built on new-model momentum, physical AI, partnerships, and international expansion, but the thesis remains conditional on commercialization, disciplined spending, and execution.

Reported Before market openNYSEConsumer Cyclical $8.93B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $-0.06 Consensus $-0.01
EPS surprise -656.6% Reported versus consensus
Reported revenue $2.86B Consensus $3.10B
Revenue surprise -7.5% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move -10.3% Event window
SPY move -0.9% Same window
Abnormal move -9.4% Stock minus SPY
Volume 2.2× Versus trailing sessions
Subsequent drift -17.7% Up to 20 sessions
XPEVSPY benchmark

Ask FN2 about XPEV FY2025 Q3

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

The latest discussion shifted the focus from near-term model launches toward a broader commercialization agenda spanning extended-range vehicles, physical AI, Robotaxi, humanoid robotics, overseas production, and technology licensing.

Guidance delta

Management's guidance sentiment was raised, with the outlook centered on continued product launches, delivery growth, technology licensing, and international expansion.

Key takeaways

  • Management presented strong operating momentum alongside a broad pipeline of new vehicles and AI-related initiatives.
  • The investment case increasingly depends on converting physical-AI development and partnerships into recurring commercial revenue.
  • The market reaction was negative despite the confident operating narrative, highlighting a gap between execution ambitions and investor expectations.

Management priorities

  • Scale the new vehicle pipeline, including extended-range and dual-energy products.
  • Advance VLA 2.0, Robotaxi, and humanoid-robot programs toward commercialization.
  • Expand localized production and deepen technology-licensing partnerships, including with Volkswagen.

Follow XPEV with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
XPEV EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 4 future estimate-only quarters. Q4 '23 estimate $-3.27 Q4 '23 actual $-0.21, beat Q1 '24 estimate $-1.94 Q1 '24 actual $-0.20, beat Q2 '24 estimate $-1.26 Q2 '24 actual $-0.19, beat Q2 '25 estimate $-0.11 Q2 '25 actual $-0.07, beat Q3 '25 estimate $-0.01 Q3 '25 actual $-0.06, miss Q4 '25 estimate $0.00 Q4 '25 actual $0.06, beat Q1 '26 estimate $-0.11 Q1 '26 actual $-0.27, miss Q2 '26 estimate $-0.06 Q2 '26 actual $-0.21, miss Q3 '26 estimate $-0.11 Q4 '26 estimate $-0.12 Q1 '27 estimate $-0.34 Q2 '27 estimate $-0.28
Show 1 more >

Analyst Consensus ?

ConsensusHold17 ratings
Bullish1058.8%
Neutral423.5%
Bearish317.7%

Analyst 52W Price Targets

$9.55Current
$4.2Low
$22.23Average
$72High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 6, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
JP Morgan Neutral OverweightDowngradeSep 29, 2026
Barclays Underweight UnderweightMaintainAug 26, 2026
Macquarie Outperform NeutralUpgradeMay 29, 2026
Freedom Capital Markets Buy HoldUpgradeJan 6, 2026
Freedom Broker Buy HoldUpgradeJan 6, 2026
Citigroup Buy BuyMaintainAug 20, 2025
B of A Securities Buy BuyMaintainAug 19, 2025
UBS Neutral SellUpgradeFeb 24, 2025
China Renaissance Buy HoldUpgradeNov 22, 2024
Bernstein Market Perform Market PerformMaintainNov 20, 2024
Morgan Stanley Overweight OverweightMaintainMar 11, 2024
CLSA Buy OutperformMaintainAug 8, 2023
HSBC Buy HoldUpgradeAug 7, 2023
Jefferies Buy HoldUpgradeJul 28, 2023
BOCOM International Sell NeutralDowngradeJul 7, 2023
Daiwa Capital Sell BuyDowngradeDec 14, 2022
Nomura Instinet Neutral BuyDowngradeJul 1, 2022
Show less

Named analyst price targets

Upside is calculated against the persisted current price $9.55. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
UBSPaul Gong$12$10.93 +25.7%Sep 9, 2026
BarclaysJiong Shao$14$11.15 +46.6%Aug 25, 2026
BarclaysAnalyst unavailable$15$13.78 +57.1%Jul 16, 2026
JefferiesAlexious Lee$25.2$16.44 +163.9%May 29, 2026
MacquarieEugene Hsiao$19$16.44 +99.0%May 28, 2026
BarclaysAnalyst unavailable$17$17.84 +78.0%Feb 18, 2026
MacquarieEugene Hsiao$26$20.9 +172.3%Jan 15, 2026
Loop Capital MarketsRoman Lukianchikov$25$20.14 +161.8%Jan 6, 2026
Morgan StanleyTim Hsiao$34$26.04 +256.0%Nov 11, 2025
Goldman SachsTina Hou$24$18.57 +151.3%Jun 17, 2025
Morgan StanleyTim Hsaio$28$19.23 +193.2%Jun 12, 2025
BernsteinEunice Lee$19$20.5 +99.0%May 22, 2025
MacquarieEugene Hsiao$24$22.25 +151.3%May 21, 2025
BernsteinAnalyst unavailable$18$23.8 +88.5%Mar 19, 2025
CMB International SecuritiesJi Shi$16$12.64 +67.5%Nov 20, 2024
Morgan StanleyTim Hsiao$17$12.88 +78.0%Nov 6, 2024
CitigroupJeff Chung$14.6$12.72 +52.9%Sep 30, 2024
CitigroupJeff Chung$10.3$10.7 +7.9%Sep 24, 2024
MacquarieEugene Hsiao$10$8.41 +4.7%Sep 3, 2024
CitigroupJeff Chung$7.6$6.77 -20.4%Aug 21, 2024
BarclaysJiong Shao$7$6.77 -26.7%Aug 21, 2024
DaiwaKelvin Lau$11$8.1 +15.2%May 23, 2024
BernsteinEunice Lee$12$8.77 +25.7%May 22, 2024
BarclaysJiong Shao$8$8.77 -16.2%May 22, 2024
CFRAAaron Ho$8$7.76 -16.2%Apr 1, 2024
HSBCYuqian Ding$18.7$8.52 +95.8%Mar 22, 2024
Morgan StanleyTim Hsiao$18$9.89 +88.5%Mar 19, 2024
Morgan StanleyTim Hsiao$18.7$21.89 +95.8%Jul 28, 2023
J.P. MorganAnalyst unavailable$9$10.09 -5.8%Jan 11, 2023
DaiwaAnalyst unavailable$8$10.25 -16.2%Dec 14, 2022
HSBCAnalyst unavailable$15$10.47 +57.1%Dec 13, 2022
JefferiesAnalyst unavailable$4.2$7.07 -56.0%Nov 28, 2022
UBSAnalyst unavailable$13$7.76 +36.1%Nov 17, 2022
CitigroupAnalyst unavailable$27.87$18.73 +191.8%Aug 24, 2022
BarclaysJiong Shao$22$18.73 +130.4%Aug 23, 2022
NomuraMartin Heung$36.3$31.74 +280.1%Jul 1, 2022
CitigroupAnalyst unavailable$51.59$28.17 +440.2%Jun 21, 2022
J.P. MorganAnalyst unavailable$35$20.8 +266.5%May 24, 2022
BarclaysAnalyst unavailable$30$20.59 +214.1%May 24, 2022
US Tiger SecuritiesBo Pei$40$20.76 +318.8%May 24, 2022
UBSPaul Gong$34$25.87 +256.0%Apr 18, 2022
BernsteinEunice Lee$56$46.24 +486.4%Oct 28, 2021
Deutsche BankEdison Yu$51$40.28 +434.0%Aug 27, 2021
Credit SuisseBin Wang$72$43.39 +653.9%Aug 2, 2021
Show less

Track every rating change on XPEV the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Operating within the People's Republic of China, XPeng Inc. is an innovator in the electric vehicle (EV) sector, focusing on the creation and sale of intelligent, connected automobiles. It handles the entire process from conceptualization to market distribution. Its diverse lineup caters to various consumer needs, featuring SUV models like the G3 and G3i, the P7 performance-oriented sports sedan, and the P5, designed as a family-friendly sedan. Beyond manufacturing vehicles, XPeng supports its customers with a comprehensive ecosystem of services. These encompass sales and financial solutions (including contracts, leasing, and loan referrals), vehicle upkeep (maintenance and super charging), and a range of digital and convenience offerings such as insurance agency, ride-hailing, technical assistance, and music subscriptions. The company was established in 2015, with its headquarters located in Guangzhou, China.

Historical context

All XPEV earnings

Consumer Cyclical peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the XPEV recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-10-06T17:30:44.062088+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-06T17:30:44.059048+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-06. For educational purposes only; not investment advice.